Clinical Results Of Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis, Our Experience At Short-Term Follow Up
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- Change in Visual Analogic Scale
研究概览
简要总结
It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection), T2 (three months after the last injection) and T3 (six months after the last injection).
Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue Scale (VAS) were administered at each evaluation.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years old;
- •Supraspinatus tendinosis detected by MRI.
排除标准
- •Supraspinatus rupture;
- •Previous shoulder surgery;
- •Rotator cuff tears secondary to fracture;
- •Hemoglobin <7 g/dL or Platelets < 30,000 microL;
- •Active infection;
- •Pregnant patients;
- •Patients with hematologic and oncologic diseases.
结局指标
主要结局
Change in Visual Analogic Scale
时间窗: Day 0; Month 1; Month 3; Month 6 (after the injection)
The shoulder pain was quantified using the Visual Analogic Scale ranging from 0 (no pain) to 10 (worst imaginable pain).
次要结局
未报告次要终点
